Andrew Aronsohn, MD

Assistant Professor of Medicine

Gastroenterologist and hepatologist Andrew Aronsohn, MD, is a specialist in the diagnosis and management of liver diseases. Dr. Aronsohn has particular expertise in treating hepatitis C and in evaluating patients for liver transplantation. He is a member of the University of Chicago Center for Liver Diseases, a multidisciplinary center nationally known for its broad experience, research discoveries, and treatment innovations related to liver diseases and transplantation.

Dr. Aronsohn researches and evaluates new treatments for liver disease. He is currently studying different types of therapies for elderly patients with hepatitis C. Also a medical ethicist, Dr. Aronsohn is investigating the principles involved in the allocation of organs for transplantation.

Practice Locations

The University of Chicago Medicine
5841 S. Maryland Avenue
Chicago, IL 60637

Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

150 E. Huron Street
Suite 900
Chicago, IL 60611

Year Started Practice

2005

Board Certifications

Internal Medicine
Gastroenterology
Transplant Hepatology

Medical School

University of Florida

Internship, Residency, and Fellowship

The University of Chicago Medicine

Membership

American Association for the Study of Liver Disease

Language Spoken

English

Email

aaronsoh@medicine.bsd.uchicago.edu

Office Phone

(773) 702-2300

Office Fax

(773) 702-2182

Office Postal Address

Andrew Aronsohn, MD
The University of Chicago Medicine
5841 S. Maryland Avenue, MC 7120
Chicago, IL 60637

Clinical Interests

• Liver diseases
• Liver transplantation
• Hepatitis C
• Viral hepatitis
• Liver cancer
• Gastroenterology
• Colon cancer
• Rectal cancer
• Medical ethics

Request an appointment online
or call UCM Connect at
1-888-824-0200

150 E. Huron Street
Request an appointment online
or call (773) 834-4150

Physicians, contact the
Referring Physician Access Line
at 1-877-DOM-2730

Learn More About Dr. Aronsohn

Dr. Aronsohn is featured in a story about breakthrough treatments for hepatitis C that have greatly improved cure rates.

The University of Chicago Medicine's Science Life blog features Dr. Aronsohn in a series of brief videos discussing new therapies for hepatitis C, including what patients can expect and why it's important to choose the right time to start the therapy.

Selected Publications

View a partial list of Dr. Aronsohn's publications through the National Library of Medicine's PubMed online database.